Medical Oncology - Dana-Farber Cancer Institute

Transcription

SELECTED
PHYSICIAN PROFILES
Dedicated to Discovery … Committed to Care
www.dana-farber.org
Table of Contents
About Dana-Farber Cancer Institute
Breast Oncology
Cancer Genetics and Prevention
Cutaneous Oncology
Early Drug Development Center
Gastrointestinal Cancer
Genitourinary Oncology
Head and Neck Cancer
Hematologic Oncology
Neuro-Oncology
Palliative Care (Adult)
Thoracic Oncology
Department of Imaging
Radiation Oncology
DF/BWCC at Milford
DF/BWCC with South Shore Hospital
Dana-Farber/NHOH
Dana-Farber Community Cancer Care
Pediatric Blood Disorders
Pediatric Brain Tumors
Pediatric Hematologic Malignancies
Pediatric Psychosocial Oncology
Pediatric Solid Tumors
Pediatric Surgical Oncology
www.dana-farber.org
3
4
6
8
10
12
16
18
20
23
25
27
29
31
33
35
37
39
41
43
45
47
49
51
2
About Dana-Farber Cancer Institute
For more than 60 years, Dana-Farber Cancer Institute has had one goal: to reduce the suffering
caused by cancer through advanced clinical care and cutting-edge scientific research. As a principal
teaching affiliate of Harvard Medical School, we are able to attract many of the best and brightest
physicians in the world to pursue this mission.
At Dana-Farber, we are committed to a multidisciplinary, compassionate, and collaborative model of care
that truly puts patients and their families at the center of all we do. We work in teams organized around
combating specific types of cancer, and patients have easy and direct access to the full range of specialists
they may need.
Our scientific research is focused on understanding the biology of cancer cells in order to develop more
effective therapies that improve patient outcomes. Our lab scientists and clinicians collaborate closely to
quickly translate findings from the lab into therapies that can be delivered to patients in our clinics.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a NCIdesignated Comprehensive Cancer Center. DF/HCC harnesses the expertise and resources of DanaFarber and six other Harvard-affiliated hospitals and research institutions to conduct research focused on
improving the understanding and treatment of cancer. Dana-Farber is also a founding member of the
National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers, working
together to develop cancer treatment guidelines and research that improves the quality and effectiveness
of cancer care. In addition, Dana-Farber has earned “Magnet” status, recognizing the Institute’s highquality patient care, nursing excellence, and innovations in professional nursing practice.
www.dana-farber.org
3
Breast Oncology
The Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber provides comprehensive care for women with all
types of breast cancer, including ductal carcinoma in situ, infiltrating (invasive) ductal carcinoma, lobular carcinoma in situ, infiltrating (invasive)
lobular carcinoma, inflammatory breast cancer, Paget’s disease, and phylloides tumor. We offer specialized expertise for patients with metastatic
breast cancer or breast cancer during pregnancy, as well as an Inflammatory Breast Cancer Program, and the Program for Young Women with Breast
Cancer which addresses the unique needs of women under 40 who are diagnosed with breast cancer. Experts in the Cancer Genetics and Prevention
Program can also create a personalized plan for women at higher risk for developing breast or ovarian cancer.
Patients receive care from a multidisciplinary team of health care professionals with extensive experience and expertise in the unique needs of
women with breast cancer. This includes medical, surgical, and radiation oncologists specializing in breast cancer, as well as radiologists,
pathologists, reproductive medicine specialists, plastic surgeons, oncology nurses, genetic counselors, and more.
Clinical research is a vital aspect of our mission at the Breast Oncology Program. We believe that outstanding clinical care is directly linked to an
active program of clinical research. Physician-researchers take the questions that arise from their experiences in the clinic, answer them through
clinical trials, and take this new knowledge back to the clinic, where it can benefit patients.
At any given time, dozens of research studies involving hundreds of patients are under way within the Breast Oncology Program. These studies are
broad in scope: investigations of prevention and early-detection strategies, new therapies, novel combinations of existing treatments, quality-of-life
studies, and laboratory analyses of tumor samples to better understand the relationship between tumor types and patient outcomes.
Our team is also leading the way in treating breast cancer as a complex family of diseases rather than a single disease. All tumors are assessed for
molecular markers that guide therapy and help determine eligibility for clinical trials exploring innovative new therapies.
New Patient Appointment Phone: 617-632-2175
Fax: 617-632-3715
Leadership – Breast Oncology
J. Dirk Iglehart, MD, Director, Susan F. Smith Center for Women’s Cancers
Eric P. Winer, MD, Director, Breast Oncology Program
Mehra Golshan, MD, FACS, Director, Breast Surgical Services
Jay R. Harris, MD, Chair, Radiation Oncology
Treatment Team
Medical Oncology
Craig A. Bunnell, MD, MPH, MBA
Harold J. Burstein, MD, PhD
Wendy Y. Chen, MD, MPH
Rachel A. Freedman, MD, MPH
Judy E. Garber, MD, MPH
Michael Hassett, MD, MPH
Rinath M. Jeselsohn, MD
Ian E. Krop, MD, PhD
Jennifer A. Ligibel, MD
Nancy U. Lin, MD
Erica L. Mayer, MD, MPH
Susan E. Moody, MD, PhD
Daniel Morganstern, MD
Beth Overmoyer, MD
Leroy M. Parker, MD
Ann H. Partridge, MD, MPH
Rochelle G. Scheib, MD
Lawrence N. Shulman, MD
Daniel P. Silver, MD, PhD
Sara M. Tolaney, MD, MPH
Nikhil Wagle, MD
Eric P. Winer, MD
Rachel L. Yung, MD
Pathology
Jane E. Brock, MD, PhD
Deborah A. Dillon, MD
Susan C. Lester, MD, PhD
Andrea L. Richardson, MD, PhD
Katharine Carter, MD
Laura S. Dominici, MD
Margaret M. Duggan, MD, FACS
Mehra Golshan, MD, FACS
J. Dirk Iglehart, MD
Faina Nakhlis, MD
Esther Rhei, MD
Susan L. Troyan, MD
Radiation Oncology
Jennifer R. Bellon, MD
Jay R. Harris, MD
Susan M. Pierce, MD
Rinaa S. Punglia, MD, MPH
Julia S. Wong, MD
Researcher
Myles A. Brown, MD
Surgical Oncology
Thanh U. Barbie, MD
To make an appointment,
call 877-332-4294
www.dana-farber.org
4
Breast Oncology - Medical Oncology
Title: Senior Physician
Academic Title: Assistant Clinical Professor of Medicine,
Harvard Medical School
Discipline: Medical Oncology
Phone: 857-215-2038
Fax: 617-632-1930
E-mail: rochelle_scheib@dfci.harvard.edu
Medical School: Albert Einstein College of Medicine
Residency: Beth Israel Medical Center, Internal
Medicine
Fellowships: Dana-Farber Cancer Institute,
Hematology/Oncology;
George Washington University Medical
Center, Hematology & Oncology
Board Certifications: Internal Medicine
Medical Oncology
Hematology
Areas of Expertise: Breast cancer, AIDS
Lawrence N. Shulman, MD
Title: Chief of Staff; Senior Vice President for
Medical Affairs; Director of Regional
Strategy Development and Director of
the Center for Global Medicine;
Institute Physician
Academic Title: Associate Professor of Medicine,
Phone: 617-632-2277
Medical School: Harvard Medical School
Residency: Beth Israel Hospital, Internal Medicine
Fellowship: Beth Israel Hospital, Hematology &
Oncology
Medical Oncology
Hematology
Areas of Expertise: Breast cancer, Hodgkin disease, Phase 1
trials
Fax: 617-632-2260
E-mail: lawrence_shulman@dfci.harvard.edu
Title: Physician
Academic Title: Assistant Professor of Medicine, Harvard
Medical School
Phone: 617-632-5961
Fax: 617-632-1930
Residency: University of California, San Francisco,
Internal Medicine
Fellowship: Dana-Farber/Partners CancerCare,
Hematology/Oncology
Medical Oncology
E-mail: daniel_silver@dfci.harvard.edu
Medical School: University of California, San Francisco
School of Medicine
call 877-332-4294
www.dana-farber.org
5
Cancer Genetics and Prevention
The Center for Cancer Genetics and Prevention provides genetic testing and counseling for new and established inherited cancer syndromes
including, but not limited to hereditary breast and ovarian cancer, familial pancreatic cancer, hereditary colorectal cancer, hereditary
paraganglioma-pheochromocytoma syndrome, Li-Fraumeni syndrome and gastrointestinal stromal tumors.
Our team is comprised of medical oncologists, gastroenterologists, geneticists, psychologists, surgeons, nurses, and genetic counselors. We work with
patients, family members, as well as with referring physicians to provide cancer risk assessment and develop comprehensive recommendations for
managing cancer risk. We are also actively involved in research focused on cancer risk and management.
Fax: 617-632-3433
Leadership – Cancer Genetics & Prevention
Judy E. Garber, MD, MPH, Director
Huma Q. Rana, MD, Clinical Director
Sapna Syngal, MD, MPH, Director, Gastrointestinal Cancer Genetics and Prevention Clinics
Treatment Team
Gastroenterology
Ramona Lim, MD
Sapna Syngal, MD, MPH
Medical Genetics
Huma Q. Rana, MD
Medical Oncology
Judy E. Garber, MD, MPH
Daniel Morganstern, MD
Beth Overmoyer, MD
Matthew B. Yurgelun, MD
Psychology
Andrea Farkas Patenaude, PhD
Surgical Oncology
Joel Edward Goldberg, MD
call (877) 332-4294
www.dana-farber.org
6
Cancer Genetics and Prevention - Gastroenterology
Title: Director, Gastrointestinal Cancer
Genetics and Prevention Clinics;
Director, Gastroenterology, Brigham and
Women's Hospital; Senior Physician
Academic Title: Professor of Medicine, Harvard Medical
School
Discipline: Gastroenterology
Phone: 617-632-6164
Fax: 617-632-4088
E-mail: sapna_syngal@dfci.harvard.edu
Graduate School: Harvard School of Public Health
Residency: Brigham and Women's Hospital,
Internal Medicine
Fellowship: Brigham and Women's Hospital,
Gastroenterology
Gastroenterology
Areas of Expertise: Cancer screening and prevention,
Familial cancer syndromes,
Gastrointestinal cancers
Medical School: McGill University Faculty of Medicine
Cancer Genetics and Prevention - Medical Oncology
Academic Title: Assistant Clinical Professor of Medicine,
Phone: 857-215-2038
Fax: 617-632-1930
E-mail: rochelle_scheib@dfci.harvard.edu
Medical School: Albert Einstein College of Medicine
Residency: Beth Israel Medical Center, Internal
Medicine
Fellowships: Dana-Farber Cancer Institute,
Hematology/Oncology;
George Washington University Medical
Center, Hematology & Oncology
Medical Oncology
Hematology
Areas of Expertise: Breast cancer, AIDS
Title: Physician
Medical School
Phone: 617-632-5961
Fax: 617-632-1930
Residency: University of California, San Francisco,
Internal Medicine
Fellowship: Dana-Farber/Partners CancerCare,
Hematology/Oncology
Medical Oncology
E-mail: daniel_silver@dfci.harvard.edu
Medical School: University of California, San Francisco
School of Medicine
call (877) 332-4294
www.dana-farber.org
7
Cutaneous Oncology
The Cutaneous Oncology Program is dedicated to the treatment and diagnosis of patients with lymphomas that originate in the skin; basal,
squamous, and merkel cell carcinomas of the skin; and cancer therapy-related dermatology, including cutaneous graft-versus host disease and skin
reactions to chemotherapy agents. Our team provides consultation and second opinions, evaluation and management, prevention and early
detection counseling, genetic counseling and risk assessment, screening of high-risk individuals, and histopathologic diagnosis and review. The
Cutaneous Oncology team also works closely with the Melanoma team in the diagnosis and treatment of pigmented lesions.
Patients are cared for by a multidisciplinary team of specialists and have access to specialized treatments, including Mohs surgery and other skin
surgeries, immuno- and chemotherapy, radiation therapy, and photopheresis. In addition, patients may have the opportunity to participate in the
numerous clinical trials evaluating new therapies.
Research performed by our faculty is at the cutting edge of oncology, cell biology, and immunology as they relate to skin. Many of our doctors are
involved in the Specialized Program of Research Excellence (SPORE) in Skin Cancer grant, awarded by the National Cancer Institute to promote
interdisciplinary translational research and to facilitate the exchange of information between the scientists who study skin cancer and the
physicians who treat it. Additionally, the program leverages the resources available through the Harvard Skin Disease Research Center, one of six
such centers nationally that investigate a variety of skin diseases, including cutaneous oncology.
Fax: 617-632-6727
Leadership – Cutaneous Oncology
Thomas Seth Kupper, MD, Disease Center Leader
Andrew Werchniak, MD, Clinical Director
Treatment Team
Dermatology
Allison Goddard, MD
Thomas S. Kupper, MD
Nicole R. LeBoeuf, MD
Stephanie W. Liu, MD
Chrysalyne D. Schmults, MD
Manisha Thakuria, MD
Medical Oncology
Corey S. Cutler, MD, MPH, FRCPC
David C. Fisher, MD
Eric D. Jacobsen, MD
Pathology
Scott R. Granter, MD
Alvaro C. Laga Canales, MD, MMSC
George F. Murphy, MD
Radiation Oncology
Phillip M. Devlin, MD, FACR
Andrea K. Ng, MD, MPH
call (877) 332-4294
www.dana-farber.org
8
Cutaneous Oncology - Dermatology
Chrysalyne D. Schmults, MD
Title: Director, Dermatologic Surgery, Mohs
Micrographic Surgery Center
Academic Title: Assistant Professor of Dermatology,
Discipline: Dermatology
Phone: 617-983-4626
Fax: 617-983-4504
Residencies: New York University, Dermatology;
Stanford University Medical Center,
Internal Medicine
Fellowship: Skin and Laser Specialists of New York,
Dermatology
Board Certification: Dermatology
Areas of Expertise: Dermatology, Dermatologic surgery
E-mail: cschmults@partners.org
Medical School: Yale University School of Medicine
call (877) 332-4294
www.dana-farber.org
9
Early Drug Development Center
The Early Drug Development Center (EDDC) specializes in conducting clinical trials that evaluate the safety and efficacy of new drugs for cancer
treatment. In this program, specialists who are researching exciting new ways to kill tumors or halt their growth conduct small, carefully designed
studies of experimental drugs that are in early phases of development. These trials include Phase 1 dose escalation studies, as well as studies
confirming proof-of-mechanism of novel agents and preliminary efficacy studies in patient populations with tumors harboring specific genetic
alterations. Such experimental treatments provide patients with the most innovative treatments emanating from cutting-edge scientific research.
Fax: 617-582-7922
Leadership – Early Drug Development Center
Geoffrey Shapiro, MD, PhD, Director
Treatment Team
Medical Oncology
Nicole G. Chau, MD
James M. Cleary, MD, PhD
Khanh T. Do, MD
Leena Gandhi, MD, PhD
Rana R. McKay, MD
Geoffrey Shapiro, MD, PhD
Sara M. Tolaney, MD, MPH
call 877-332-4294
www.dana-farber.org
10
Early Drug Development Center - Medical Oncology
Geoffrey Shapiro, MD, PhD
Title: Director, Early Drug Development
Center; Senior Physician
Phone: 617-632-4942
Fax: 617-632-1977
E-mail: geoffrey_shapiro@dfci.harvard.edu
Residencies: Beth Israel Hospital, Chief Medical
Resident;
Beth Israel Hospital, Internal Medicine
Fellowship: Dana-Farber Cancer Institute, Medical
Oncology
Board Certification: Medical Oncology
Areas of Expertise: Developmental therapeutics, Phase 1
clinical trials, Solid tumors
Medical School: Weill Medical College of Cornell
University
call 877-332-4294
www.dana-farber.org
11
Gastrointestinal Cancer
The Gastrointestinal Cancer Center provides advanced, integrated care for patients diagnosed with or at risk for colorectal, pancreatic, stomach,
liver, gallbladder, bile duct, and esophageal cancers, as well as neuroendocrine and carcinoid tumors. Patients are cared for by a multidisciplinary
team of specialists who use advanced, innovative techniques to diagnose and treat gastrointestinal malignancies.
Our team is a leader in delivering a personalized treatment approach for many gastrointestinal malignancies. All colorectal cancers are tested for
KRAS and BRAF mutations, with therapy tailored according to the tumor genotype. In addition, treatment for patients with esophageal and gastric
cancers is provided based on each patient’s individual HER2 amplification.
The Center offers genetic counseling and testing to patients with a family history of gastrointestinal cancers. This program also conducts research to
understand the genetic causes of cancer and to evaluate new diagnostic tests for early detection, novel endoscopic techniques, and new medical
therapies to prevent gastrointestinal cancers.
The clinical investigators in the Center conduct basic and translational research to develop more effective treatment techniques for patients with
gastrointestinal cancers, and understand the biology of gastrointestinal malignancies.
Fax: 617-582-7875
Leadership – Gastrointestinal Cancer
Charles S. Fuchs, MD, MPH, Director
Jeffrey A. Meyerhardt, MD, MPH, Clinical Director
Harvey J. Mamon, MD, PhD, Disease Center Leader, Radiation Oncology
Michael J. Zinner, MD, Disease Center Leader, Surgical Oncology
Treatment Team
Gastroenterology
Kunal Jajoo, MD
Ramona Lim, MD
John Robinson Saltzman, MD
Medical Oncology
Thomas A. Abrams, MD
Adam Bass, MD
Pankaj Bhargava, MD
Gabriel A. Brooks, MD
Jennifer Chan, MD, MPH
James M. Cleary, MD, PhD
Andrea C. Enzinger, MD
Peter C. Enzinger, MD
Charles S. Fuchs, MD, MPH
Wendy S. Garrett, MD, PhD
Wolfram Goessling, MD, PhD
Matthew H. Kulke, MD
Robert J. Mayer, MD
Nadine J. McCleary, MD, MPH
Jeffrey A. Meyerhardt, MD, MPH
Kimmie Ng, MD, MPH
Douglas Rubinson, MD, PhD
Deborah Schrag, MD, MPH
Ramesh A. Shivdasani, MD, PhD
call 877-332-4294
Brian M. Wolpin, MD, MPH
Matthew B. Yurgelun, MD
Pathology
Agoston Agoston, MD, PhD
Leona A. Doyle, MD
Jason L. Hornick, MD, PhD
Robert D. Odze, MD, FACP
Shuji Ogino, MD, PhD, MS
Amitabh Srivastava, MD
Jennifer L. Irani, MD
Michael T. Jaklitsch, MD, FACS
Abraham Lebenthal, MD
Steven J. Mentzer, MD
Richard S. Swanson, MD
Scott J. Swanson, MD
Jiping Wang, MD, PhD
Jon O. Wee, MD, FACS
Michael J. Zinner, MD
Radiation Oncology
Alec Kimmelman, MD, PhD
Harvey J. Mamon, MD, PhD
Neil E. Martin, MD, MPH
Surgical Oncology
Stanley W. Ashley, MD
Monica M. Bertagnolli, MD
Ronald Bleday, MD
Elizabeth Breen, MD
Raphael Bueno, MD
Thomas E. Clancy, MD, FACS
Daniel Michael Cohen, MD
Christopher T. Ducko, MD
Joel Edward Goldberg, MD
www.dana-farber.org
12
Gastrointestinal Cancer - Gastroenterology
John Robinson Saltzman, MD
Title: Director of Endoscopy, Brigham and
Women's Hospital
Phone: 617-732-6389
Fax: 617-566-0338
E-mail: jsaltman@partners.org
Fellowship: New England Medical Center,
Gastroenterology
Board Certification: Gastroenterology
Areas of Expertise: Barrett's esophagus, Endoscopic mucosal
resection (EMR), Endoscopic retrograde
cholangiopancreatography, Endoscopic
ultrasonography, Gastroesophageal
reflux disease (GERD), Gastrointestinal
bleeding, Interventional endoscopy
Medical School: University of North Carolina at Chapel
Hill
Residency: University Hospital Medical Center,
Internal Medicine
Title: Director, Gastrointestinal Cancer
Genetics and Prevention Clinics;
Director, Gastroenterology, Brigham and
Women's Hospital; Senior Physician
School
Phone: 617-632-6164
Fax: 617-632-4088
E-mail: sapna_syngal@dfci.harvard.edu
Graduate School: Harvard School of Public Health
Internal Medicine
Gastroenterology
Gastroenterology
Areas of Expertise: Cancer screening and prevention,
Familial cancer syndromes,
Gastrointestinal cancers
Medical School: McGill University Faculty of Medicine
Gastrointestinal Cancer - Medical Oncology
Deborah Schrag, MD, MPH
Title: Chief, Division of Population Sciences,
Department of Medical Oncology;
Senior Physician
School
Phone: 617-582-8301
Internal Medicine
Oncology
Medical Oncology
Area of Expertise: Gastrointestinal cancers
Fax: 617-582-7450
E-mail: deb_schrag@dfci.harvard.edu
Medical School: Columbia University
call 877-332-4294
www.dana-farber.org
13
Gastrointestinal Cancer - Medical Oncology
Ramesh A. Shivdasani, MD, PhD
Title: Physician
School
Phone: 617-632-5746
Fax: 617-582-7198
Internal Medicine
Oncology
Board Certification: Medical Oncology
E-mail: ramesh_shivdasani@dfci.harvard.edu
Medical School: University of Michigan School of
Medicine
Gastrointestinal Cancer - Pathology
Amitabh Srivastava, MD
Academic Title: Associate Professor of Pathology,
Discipline: Pathology
Phone: 617-732-7510
Fax: 617-264-5118
E-mail: asrivastava@partners.org
Medical School: King George's Medical College c/o
Chhatrapati Maharaj Medical
University
Residencies: King George's Medical College,
Pathology;
New England Medical Center,
Pathology;
Sanjay Gandhi Postgraduate Institute of
Medical Sciences, Pathology;
University College of Medical Sciences,
University of Delhi,
Pathology/Hematology
Fellowships: Brigham and Women's Hospital,
Gastrointestinal Pathology;
Massachusetts General Hospital,
Gastrointestinal Pathology
Board Certification: Anatomic Pathology and Clinical
Pathology
Gastrointestinal Cancer - Surgical Oncology
Richard S. Swanson, MD
Title: Director, Program in Hepatobiliary and
Pancreatic Cancer
Academic Title: Associate Professor of Surgery, Harvard
Medical School
Discipline: Surgical Oncology
Phone: 617-732-8818
Fax: 617-739-1728
E-mail: rswanson@partners.org
Residency: Massachusetts General Hospital
Fellowships: Massachusetts General Hospital,
Surgical Endoscopy;
Plymouth, England, Surgery;
The University of Texas, M. D.
Anderson Cancer Center, Surgery,
Surgical Oncology
Board Certification: Surgery
call 877-332-4294
www.dana-farber.org
14
Gastrointestinal Cancer - Surgical Oncology
Title: Chief Surgical Officer; Disease Center
Leader, Thoracic Oncology; Vice Chair
for Clinical Cancer, Department of
Surgery, Brigham and Women's Hospital
Academic Title: Professor of Surgery, Harvard Medical
School
Phone: 617-525-7532
Fax: 617-264-6373
General Surgery
Cardiothoracic Surgery
Board Certifications: Surgery
Thoracic Surgery
Areas of Expertise: Thoracic oncology, Minimally invasive
surgery, Lung cancer, Esophageal cancer,
Sarcoma, Thymoma
E-mail: sjswanson@partners.org
call 877-332-4294
www.dana-farber.org
15
Genitourinary Oncology
The Lank Center for Genitourinary Oncology provides highly-advanced, multidisciplinary care for patients with prostate, bladder, kidney, and
testicular cancers. A dedicated team of clinicians specializing in genitourinary cancers – including medical oncologists, urologic surgeons, radiation
oncologists, radiologists, pathologists and other cancer specialists – work together to provide the most effective treatment plan for each patient.
Innovative treatment approaches at the Lank Center include novel clinical trials of targeted and combination therapies; robotic surgery and
reconstructive techniques; advanced interventional radiologic techniques; and radiation therapies using real-time image guidance and
immobilization and localization techniques. In addition, clinicians and researchers actively collaborate to develop personalized treatment options
based on the specific characteristics of each patient’s tumor.
Our team is actively involved in clinical research that will improve our ability to understand and treat genitourinary malignancies. We have
multiple active research studies focused on early detection and prevention, assessment of new therapies, quality of life, and the analysis of blood and
tissue samples to better understand the biology of the diseases.
Fax: 617-632-2557
Leadership – Genitourinary Oncology
Philip W. Kantoff, MD, Director
Toni Choueiri, MD, Clinical Director
Anthony V. D’Amico, MD, PhD, Disease Center Leader, Radiation Oncology
Adam S. Kibel, MD, Disease Center Leader, Urology
Treatment Team
Medical Oncology
Joaquim Bellmunt, MD, PhD
Atish D. Choudhury, MD, PhD
Toni Choueiri, MD
Aymen Elfiky, MD, MA, MPH
William C. Hahn, MD, PhD
Lauren C. Harshman, MD
Julia Hayes, MD
Elizabeth P. Henske, MD
Philip W. Kantoff, MD
Kerry L. Kilbridge, MD, MSc
Rana R. McKay, MD
Mark Pomerantz, MD
Robert W. Ross, MD
Christopher Sweeney, MBBS
David Takeda, MD, PhD
Mary-Ellen Taplin, MD
Eliezer Van Allen, MD
Matthew Vander Heiden, MD, PhD
Channing Yu, MD, PhD
William R. Welch, MD
Radiation Oncology
Clair J. Beard, MD
Anthony V. D'Amico, MD, PhD
Paul L. Nguyen, MD
Researcher
Myles A. Brown, MD
Surgical Oncology
Steven L. Chang, MD, MS
Adam S. Kibel, MD
Mark Preston, MD, MPH
Jerome Paul Richie, MD
Graeme Steele, MD
Quoc-Dien Trinh, MD
Pathology
Justine Barletta, MD
Michelle S. Hirsch, MD, PhD
Massimo F. Loda, MD
call 877-332-4294
www.dana-farber.org
16
Genitourinary Oncology - Medical Oncology
Christopher Sweeney, MBBS
Phone: 617-632-4524
Fax: 617-632-2165
E-mail: christopher_sweeney@dfci.harvard.edu
Fellowship: Indiana University, Hematology and
Oncology
Medical Oncology
Areas of Expertise: Prostate cancer, Clinical trials,
Testicular cancer, Bladder cancer,
Kidney cancer, Hormone and
chemotherapy
Medical School: University of Adelaide, Australia
Residency: Gundersen Lutheran Medical Center,
Internal Medicine
Genitourinary Oncology - Surgical Oncology
Graeme Steele, MD
Academic Title: Assistant Professor of Surgery, Harvard
Medical School
Phone: 617-732-6325
Fax: 617-566-3475
E-mail: gsteele@partners.org
Medical Schools: College of Medicine of South Africa;
University of Witwartersrand
call 877-332-4294
Residencies: Harvard Urology Program - Brigham and
Women's Hospital, Urologic Surgery;
Johannesburg Hospital, General Surgery;
Johannesburg Hospital, Urologic Surgery
Board Certification: Urology
Areas of Expertise: Urologic oncology, Voiding dysfunction,
Urinary incontinence and urodynamic
studies, Bladder cancer, Renal cancer,
Prostate cancer, Testis cancer
www.dana-farber.org
17
Head and Neck Cancer
The Head and Neck Cancer Center at Dana-Farber Cancer Institute is the region’s most comprehensive program dedicated exclusively to patients
with head and neck cancers. Specialists evaluate and treat all types and stages of head and neck cancers, from early lesions to rare and challenging
cases. Our team has extensive experience in managing the complex treatment required for head and neck cancer patients. The patient’s care team
includes specialists from numerous disciplines including head and neck surgery, medical and radiation oncology, pathology, dentistry, oral surgery,
reconstructive surgery, nutrition services, social work, speech, voice, and swallowing therapy.
The creation of new and better ways to treat head and neck cancers, and manage the side effects of treatment, is an important focus for the
physician-researchers in our program. As a result, patients have access to trials of innovative treatments developed at Dana-Farber as well as at other
U.S. medical centers through national collaborative groups.
Our group is a leader in understanding and treating oropharynx cancers caused by HPV. Patients with this type of cancer undergo HPV molecular
testing which is the most important marker for prognosis and treatment planning in head and neck cancer. Our clinicians have also developed
therapeutic trials to address treatment intensity for patients with HPV tumors.
Fax: 617-632-4448
Leadership – Head and Neck Cancer
Robert I. Haddad, MD, Disease Center Leader
Roy B. Tishler, MD, PhD, Disease Center Leader, Radiation Oncology
Charles M. Norris, Jr., MD, FACS, Disease Center Leader, Surgery
Treatment Team
Laryngology
Surgical Oncology
Neil Bhattacharyya, MD, FACS
Donald J. Annino, Jr., MD, DMD
Laura Ann Goguen, MD
Charles M. Norris, Jr., MD, FACS
Tom Thomas, MD, MPH
Medical Oncology
Nicole G. Chau, MD
Robert I. Haddad, MD
Jochen H. Lorch, MD, MS
Guilherme Rabinowits, MD
Neurosurgery
Ian F. Dunn, MD
Oral Medicine
Hani H. Mawardi, DMD, DMSc
Stephen T. Sonis, DMD, DMSc
Nathaniel Simon Treister, DMD, DMSc
Pathology
Vickie Young Jo, MD
Jeffrey F. Krane, MD, PhD
Radiation Oncology
Danielle N. Margalit, MD, MPH
Jonathan D. Schoenfeld, MD, MPhil, MPH
Roy B. Tishler, MD, PhD
call 877-332-4294
www.dana-farber.org
18
Head and Neck Cancer - Oral Medicine
Stephen T. Sonis, DMD, DMSc
Academic Title: Professor of Oral Medicine and
Diagnostic Services, Harvard Medical
School
Discipline: Oral Medicine
Phone: 857-228-1102
Fax: 617-525-6899
E-mail: ssonis@partners.org
Medical School: Tufts University School of Medicine
Residency: Harvard University Combined
Doctorate and Specialty Training
Program
Fellowship: Oxford University
Board Certifications: Dentistry
Periodontics
Oral Medicine
Areas of Expertise: Initiation of clinical studies on the oral
complications of cancer therapy, Biology
and clinical significance of cancer
regimen-related mucosal toxicities,
Clinical, biological and health economic
aspects of oral complications of cancer
therapy
Head and Neck Cancer - Radiation Oncology
Title: Physician
Academic Title: Instructor in Radiation Oncology,
Discipline: Radiation Oncology
Residency: Harvard Radiation Program, Radiation
Oncology
Fellowship: Harvard School of Public Health
Area of Expertise: Head and neck cancers
Phone: 617-632-3591
Fax: 617-632-4247
E-mail: jschoenfeld@lroc.harvard.edu
call 877-332-4294
www.dana-farber.org
19
Hematologic Oncology
The Center for Hematologic Oncology provides highly-specialized care for adult patients with all types of blood disorders, including leukemia,
lymphoma, multiple myeloma, and Waldenstrom’s Macroglobulinemia, as well as related blood disorders such as aplastic anemia and myelodysplasia.
Patients receive world-class care from a full array of specialists including hematologic oncologists, radiation oncologists, hematopathologists,
infectious disease specialists, specialized nursing professionals, oncology pharmacists and psychosocial support specialists. This team develops a
personalized treatment plan for each patient, offering the latest therapies and supportive care.
Our Center is dedicated to advancing care through innovative research. We offer more than 100 active therapeutic clinical trials through DanaFarber/Harvard Cancer Center, providing patients with access to the latest therapies.
New Appointment Phone:
Adult Leukemia: 617-632-6028
Lymphoma: 617-632-6246
Multiple Myeloma: 617-632-3823
Stem Cell Transplantation: 617-632-3245
Waldenström's Macroglobulinemia: 617-632-3823
Fax (all programs): 617-632-3730
Leadership – Center for Hematologic Oncology
Robert J. Soiffer, MD, Chief, Division of Hematologic Malignancies and Co-Chief, Stem Cell Transplantation
Richard M. Stone, MD, Program Director, Adult Leukemia
Daniel J. DeAngelo, MD, PhD, Director of Clinical and Translational Research, Adult Leukemia
Martha Wadleigh, MD, Clinical Director, Adult Leukemia
Margaret A. Shipp, MD, Chief, Division of Hematologic Neoplasia and Program Director, Lymphoma
Eric D. Jacobsen, MD, Clinical Director, Lymphoma
Jennifer R. Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center
Kenneth C. Anderson, MD, Program Director, Multiple Myeloma
Paul G. Richardson, MD, Clinical Program Leader and Director of Clinical Research, Multiple Myeloma
Nikhil C. Munshi, MD, Director of Basic and Correlative Science, Multiple Myeloma
Jacob Laubach, MD, MPP, Clinical Director, Multiple Myeloma
Joseph H. Antin, MD, Chief, Stem Cell Transplantation
Edwin P. Alyea, III, MD, Associate Director, Stem Cell Transplantation
Vincent T. Ho, MD, Clinical Director, Stem Cell Transplantation
Steven P. Treon, MD, PhD, Director, Waldenström's Macroglobulinemia
Treatment Team
Infectious Disease
Lindsey Robert Baden, MD
Sarah Page Hammond, MD
Nicolas C. Issa, MD
Sophia Koo, MD
Francisco Marty, MD
Medical Oncology
Gregory A. Abel, MD, MPH
Edwin P. Alyea, III, MD
Kenneth C. Anderson, MD
Joseph H. Antin, MD
Philippe Armand, MD, PhD
Bradley Blaser, MD, PhD
James E. Bradner, MD
Jennifer R. Brown, MD, PhD
George P. Canellos, MD
Jorge J. Castillo, MD
Corey S. Cutler, MD, MPH, FRCPC
Matthew S. Davids, MD
Daniel J. DeAngelo, MD, PhD
James A. DeCaprio, MD
David C. Fisher, MD
David A. Frank, MD, PhD
Arnold S. Freedman, MD
call 877-332-4294
Irene Ghobrial, MD
Brett E. Glotzbecker, MD
James D. Griffin, MD
Vincent T. Ho, MD
Eric D. Jacobsen, MD
Caron A. Jacobson, MD
John Koreth, MD, PhD
Ann S. LaCasce, MD
Andrew A. Lane, MD, PhD
Jacob Laubach, MD, MPP
Anthony G. Letai, MD, PhD
R. Coleman Lindsley, MD, PhD
Jens G. Lohr, MD, PhD
Ann Mullally, MD
Nikhil C. Munshi, MD
Lee M. Nadler, MD
Sarah Nikiforow, MD, PhD
Oreofe O. Odejide, MD
Claudia Paba-Prada, MD
Paul G. Richardson, MD
Jerome Ritz, MD
Robert L. Schlossman, MD
Margaret A. Shipp, MD
Robert J. Soiffer, MD
David P. Steensma, MD
Richard M. Stone, MD
Steven P. Treon, MD, PhD
Martha Wadleigh, MD
David M. Weinstock, MD
Catherine J. Wu, MD
Rushdia Yusuf, MD
Pathology
Jon C. Aster, MD, PhD
Ruben Carrasco, MD
David M. Dorfman, MD, PhD
Michael J. Kluk, MD, PhD
Frank C. Kuo, MD, PhD
Scott B. Lovitch, MD, PhD
Geraldine S. Pinkus, MD
Olga Pozdnyakova, MD, PhD
Scott J. Rodig, MD, PhD
Radiation Oncology
Peter M. Mauch, MD
www.dana-farber.org
20
Hematologic Oncology - Medical Oncology
Robert L. Schlossman, MD
Title: Institute Physician
Medical School
Phone: 617-632-2127
Fax: 617-632-6624
E-mail: robert_schlossman@dfci.harvard.edu
Medical School: Tufts University School of Medicine
Residency: Mount Sinai Hospital, Internal
Medicine
Fellowships: Brigham and Women's Hospital,
Oncology;
Georgetown University Medical Center,
Hematology
Medical Oncology
Areas of Expertise: Bone marrow transplantation,
Immunotherapy, Multiple myeloma
Margaret A. Shipp, MD
Title: Chief, Division of Hematologic
Neoplasia; Program Director, Lymphoma
Program; Senior Physician
School
Phone: 617-632-3874
Fax: 617-632-4734
E-mail: margaret_shipp@dfci.harvard.edu
Residency: Washington University School of
Medicine, Internal Medicine
Fellowships: Dana-Farber Cancer Institute, Medical
Oncology;
Washington University School of
Medicine, Immunology Research Fellow
Medical Oncology
Areas of Expertise: Bone marrow transplantation,
Lymphoma, Hodgkin disease
Medical School: Washington University School of
Medicine
Robert J. Soiffer, MD
Title: Vice Chair, Department of Medical
Oncology; Chief, Division of
Hematologic Malignancies; Co-Chief,
Stem Cell Transplantation; Institute
Physician
School
Phone: 617-632-6256
Fax: 617-632-5168
E-mail: robert_soiffer@dfci.harvard.edu
Medical School: New York University
call 877-332-4294
Residencies: Brigham and Women's Hospital, Chief
Medical Resident;
Brigham and Women's Hospital,
Internal Medicine;
West Roxbury Veterans Administration
Medical Center, Chief Medical Resident
Fellowship: Dana-Farber Cancer Institute,
Hematology & Oncology
Medical Oncology
Areas of Expertise: Stem cell/bone marrow transplantation,
Leukemia, Lymphoma, Chronic
lymphocytic leukemia
www.dana-farber.org
21
Hematologic Oncology - Medical Oncology
David P. Steensma, MD
Phone: 617-632-3712
Fax: 617-582-7840
E-mail: david_steensma@dfci.harvard.edu
Residency: Mayo Clinic
Fellowships: Institute of Molecular Medicine,
University of Oxford;
Mayo Clinic, Hematology/Oncology
Hematology
Medical Oncology
Area of Expertise: Myelodysplastic syndromes
Medical School: University of Chicago Pritzker School of
Medicine
Richard M. Stone, MD
Title: Program Director, Adult Leukemia;
Institute Physician
School
Phone: 617-632-1906
Fax: 617-632-2933
E-mail: richard_stone@dfci.harvard.edu
call 877-332-4294
Residencies: Brigham and Women's Hospital, Chief
Medical Resident;
Brigham and Women's Hospital,
Internal Medicine
Fellowship: Dana-Farber Cancer Institute,
Hematology/Oncology
Medical Oncology
Hematology
Area of Expertise: Leukemia, Myelodysplastic syndromes,
Myeloproliferative disorders
www.dana-farber.org
22
Neuro-Oncology
The Center for Neuro-Oncology provides expert care for patients with primary and metastatic brain tumors, spinal cord cancer, and neurologic
complications from cancer and its treatment. Care is coordinated by a team of clinicians specializing in neuro-oncology, neurosurgery, radiation
oncology, psychosocial oncology, nursing, neuropathology, neuropsychology, social work, and genetic counseling. Through our multidisciplinary
clinic, patients have the benefit of meeting with our team of surgical, medical, and radiation oncologists at one time and in one place to develop
individualized treatment plans.
Clincal care is supported by a strong clinical and basic science research program. The clinical research program is a leader in neuro-oncology clinical
trials, including immunotherapy, targeted therapies and inhibitors of angiogenesis. In addition, by routinely testing patients with glioblastoma and
anaplastic gliomas for common mutations, we are able to tailor treatment plans for patients. The basic science program aims to enhance the
understanding of neurologic cancers, including why tumors develop in the brain, and the mechanisms that drive tumor growth and resistance to
therapy. Our investigators also collaborate with the North American Brain Tumor Consortium, National Cancer Institute, and pharmaceutical
companies to develop new approaches to the treatment of brain and spinal cord tumors.
Fax: 617-632-4773
Leadership – Neuro-Oncology
Patrick Y. Wen, MD, Director
David Reardon, MD, Clinical Director
Brian M. Alexander, MD, MPH, Disease Center Leader, Radiation Oncology
Ennio A. Chiocca, MD, PhD, Disease Center Leader, Neurosurgery
Treatment Team
Neuro-Oncology
Pathology
Rameen Beroukhim, MD, PhD
Eudocia Q. Lee, MD, MPH
Lakshmi Nayak, MD
Andrew Norden, MD, MPH
David Reardon, MD
Mikael Rinne, MD, PhD
Patrick Y. Wen, MD
Umberto De Girolami, MD
Mel B. Feany, MD, PhD
Rebecca Dunn Folkerth, MD
Hart G. Lidov, MD
Keith L. Ligon, MD, PhD
Sandro Santagata, MD, PhD
Neurosurgery
Ossama Al-Mefty, MD
John H. Chi, MD, MPH
Ennio A. Chiocca, MD, PhD
Elizabeth B. Claus, MD, PhD
Rose Du, MD, PhD
Ian F. Dunn, MD
Kai U. Frerichs, MD
Alexandra Golby, MD
William Brian Gormley, MD, MPH
Michael W. Groff, MD
Mark D. Johnson, MD, PhD
Edward R. Laws, MD, FACS
Travis S. Tierney, MD, PhD
call 877-332-4294
Radiation Oncology
Ayal Aizer, MD, MHS
Brian M. Alexander, MD, MPH
Nils Arvold, MD
Karen J. Marcus, MD
www.dana-farber.org
23
Neuro-Oncology - Pathology
Academic Title: Assistant Professor of Pathology,
Neuropathology
Phone: 617-732-7510
E-mail: ssantagata@partners.org
Medical School: Mount Sinai School of Medicine
Anatomic and Clinical Pathology
call 877-332-4294
www.dana-farber.org
24
Palliative Care (Adult)
Palliative care is: “…an active and systematic approach to addressing issues that are important to patients and families in the setting of serious
illness … aimed at yielding improvements in quality of life and relief of suffering. It is focused on optimizing people’s function and comfort in the
shadow of a limited life expectancy in all of the domains that make us who we are: physical, emotional, spiritual, sexual, social and financial” (Ferris
FD, et al. J Clin Oncol 2009; 27:3052-8).
Palliative care is not limited to care at the end of life — that is hospice care. Palliative care is appropriate for all cancer patients, from diagnosis on,
and we focus both on helping them and providing support for their families. Our inpatient and outpatient adult palliative care teams include expert
physicians, nurse practitioners, physician assistants, nurses, social workers, pharmacists and chaplains.
We offer outpatient consultations for patients cared for by Dana-Farber oncologists, and inpatient consultations at Brigham and Women’s Hospital
to patients with cancer and other diagnoses cared for at Brigham and Women's Hospital. In addition, our Inpatient Palliative Care Unit team cares
for oncology patients with the most severe palliative care problems.
Leadership – Adult Palliative Care
Susan D. Block, MD, Chair, Department of Psychosocial Oncology and Palliative Care
Kathy J. Selvaggi, MD, MS, Clinical Director
Treatment Team
Palliative Medicine
Janet L. Abrahm, MD
Rachelle E. Bernacki, MD, MS
Douglas E. Brandoff, MD
Andrea C. Enzinger, MD
John David Halporn, MD
Joshua R. Lakin, MD
Lida Nabati, MD
Sanjeet Narang, MD
Elizabeth M. Rickerson, MD
Justin J. Sanders, MD, MSc
Kristen Schaefer, MD
Kathy J. Selvaggi, MD, MS
Jane deLima Thomas, MD
Irene M. Yeh, MD, MPH
call 877-332-4294
www.dana-farber.org
25
Palliative Care (Adult) - Palliative Medicine
Justin J. Sanders, MD, MSc
Title: Physician
Academic Title: Instructor in Medicine, Harvard Medical
School
Discipline: Palliative Medicine
Phone: 617-632-6464
Fax: 617-632-6180
E-mail: justin_sanders@dfci.harvard.edu
Residency: Montefiore Medical Center, Family and
Social Medicine
Fellowship: Massachusetts General Hospital,
Palliative Care
Board Certification: Family Medicine
Areas of Expertise: Disparities in health care, Access,
Underserved populations, Addiction
Medical School: University of Vermont College of
Medicine
Kristen Schaefer, MD
Title: Director of Residency Education;
Physician
Academic Title: Instructor in Medicine, Harvard Medical
School
Phone: 617-632-6464
Fax: 617-632-6180
Residency: University of California, San Francisco
Primary Care Program, Internal
Medicine
Hospice and Palliative Medicine
Areas of Expertise: Palliative medicine, Symptom
management, End-of-life care
E-mail: kristen_schaefer@dfci.harvard.edu
Kathy J. Selvaggi, MD, MS
Title: Director, Inpatient Palliative Care Unit,
Brigham and Women's Hospital/DanaFarber Cancer Institute; Senior
Physician
Medical School
Phone: 617-632-5742
Residencies: Shadyside Hospital, Chief Medical
Resident;
University of Pittsburgh, Internal
Medicine
Fellowships: Dana-Farber Cancer Institute, Palliative
Care;
University of Pittsburgh Medical Center,
Hematology/Oncology
E-mail: kselvaggi@partners.org
Medical Oncology
Hospice and Palliative Medicine
Medical School: Penn State University College of
Medicine
Areas of Expertise: Palliative medicine, Symptom
management, End-of-life care
Fax: 617-632-6180
call 877-332-4294
www.dana-farber.org
26
Thoracic Oncology
The Lowe Center for Thoracic Oncology provides expert care for patients with lung cancer, malignant mesothelioma, mediastinal and thymic
tumors, and metastatic cancers to the chest. Because most patients require therapy that includes a combination of chemotherapy, radiation, and
surgery, care is coordinated among a specialized team that includes thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists,
radiologists, pathologists, nurses, physical therapists, respiratory therapists, dieticians and nutritionists, and social workers. We perform routine
genomic testing of tumors from all patients with advanced non-small cell lung cancer using the latest next generation sequencing methods to
evaluate for changes in over 300 genes. We offer a wide variety of therapeutic approaches and clinical trials of novel therapies based on the genomic
makeup of the individual patient’s cancer.
In addition to providing superior standard treatment options, the thoracic oncology team is involved in clinical and laboratory research to identify
innovative treatment strategies for thoracic malignancies. Our physicians are also leaders in national cooperative group studies through the Alliance
for Clinical Trials in Oncology. As a result of this cutting-edge research, most patients will be offered the opportunity to participate in a clinical
trial as one of their treatment options.
Fax: 617-632-4413
Leadership Team – Thoracic Oncology
Scott J. Swanson, MD, Disease Center Leader
Pasi A. Jänne, MD, PhD, Director
Michael S. Rabin, MD, Clinical Director
Aileen B. Chen, MD, MPP, Disease Center Leader, Radiation Oncology
Treatment Team
Medical Oncology
Mark Awad, MD, PhD
David A. Barbie, MD
Leena Gandhi, MD, PhD
Stacy W. Gray, MD, AM
Peter Hammerman, MD, PhD
David M. Jackman, MD
Joseph Jacobson, MD
Pasi A. Jänne, MD, PhD
Bruce E. Johnson, MD
David J. Kwiatkowski, MD, PhD
Christopher Lathan, MD, MS, MPH
J. Paul Marcoux, II, MD
Geoffrey R. Oxnard, MD
Michael S. Rabin, MD
Michael J. Vasconcelles, MD
Frederick Wilson, MD, PhD
Kwok-Kin Wong, MD, PhD
Pathology
Lucian R. Chirieac, MD
Joseph M. Corson, MD
John J. Godleski, MD
Lester Kobzik, MD
Robert F. Padera, Jr., MD, PhD
call 877-332-4294
Lynette M. Sholl, MD
Pulmonology
Victor M. Pinto-Plata, MD
Gerald L. Weinhouse, MD
Radiation Oncology
Elizabeth H. Baldini, MD, MPH
Aileen B. Chen, MD, MPP
David E. Kozono, MD, PhD
Raymond H. Mak, MD
Julia S. Wong, MD
Surgical Oncology
Raphael Bueno, MD
Phillip C. Camp, Jr., MD
Daniel Michael Cohen, MD
Yolonda L. Colson, MD, PhD
Ciaran J. McNamee, MD
Steven J. Mentzer, MD
Brian Whang, MD
www.dana-farber.org
27
Thoracic Oncology - Pathology
Lynette M. Sholl, MD
Thoracic Pathology
Phone: 617-732-5985
Fax: 617-264-5118
E-mail: lmsholl@partners.org
Medical School: Stanford University School of Medicine
Thoracic Oncology - Surgical Oncology
Title: Chief Surgical Officer; Disease Center
Leader, Thoracic Oncology; Vice Chair
for Clinical Cancer, Department of
Surgery, Brigham and Women's Hospital
School
Phone: 617-525-7532
Fax: 617-264-6373
General Surgery
Cardiothoracic Surgery
Board Certifications: Surgery
Thoracic Surgery
Areas of Expertise: Thoracic oncology, Minimally invasive
surgery, Lung cancer, Esophageal cancer,
Sarcoma, Thymoma
E-mail: sjswanson@partners.org
call 877-332-4294
www.dana-farber.org
28
Department of Imaging
The Department of Imaging offers a complete range of diagnostic examinations using state-of-the-art, fully accredited imaging equipment as well as
various systemic radioisotope therapies. The members of the imaging team are multimodality and whole body imaging experts in cancer imaging
who focus on specialized consultative and interpretive cancer imaging services, individualized patient care, and optimal communication with our
clinical providers. Our radiologists, technologists, nurses and staff are committed to provide high quality, personalized, and compassionate care to
our patients while maintaining the highest safety and quality standards and enabling translational cancer research and drug development through
the use of imaging.
New Patient Appoinment Phone: (617) 632-4444
Leadership – Department of Imaging
Annick D. Van den Abbeele, MD, Chief
Treatment Team
Radiology
Russell A. Blinder, MD
Donald N. Di Salvo, MD
Pamela J. DiPiro, MD
Fiona M. Fennessy, MD, PhD
Angela A. Giardino, MD
Stephanie Howard, MD
Heather Jacene, MD
Jyothi P. Jagannathan, MD
Katherine Krajewski, MD
Jack E. Meyer, MD
Mizuki Nishino, MD
Nikhil H. Ramaiya, MD
Michael H. Rosenthal, MD, PhD
Christopher G. Sakellis, MD
Atul B. Shinagare, MD
Annick D. Van den Abbeele, MD, FACR
call 877-332-4294
www.dana-farber.org
29
Department of Imaging - Radiology
Christopher G. Sakellis, MD
Title: Physician
Academic Title: Instructor in Radiology, Harvard
Medical School
Discipline: Radiology
Phone: 617-582-7449
Fax: 617-632-3581
E-mail: csakellis@partners.org
Residency: Tufts-New England Medical Center,
Radiology
Fellowship: Harvard Medical School Joint Program
in Nuclear Medicine, Brigham and
Women’s Hospital, Nuclear Medicine
Board Certification: Diagnostic Radiology/Nuclear Medicine
Areas of Expertise: Nuclear oncology, Neuroendocrine
tumors, Sarcoma
Medical School: University of Massachusetts Medical
School
Atul B. Shinagare, MD
Title: Physician
Academic Title: Assistant Professor of Radiology,
Discipline: Radiology
Phone: 617-632-6858
Fax: 617-582-8574
E-mail: ashinagare@partners.org
Residency: Grant Medical College and Sir JJ Group
of Hospitals, India
Fellowship: Dana-Farber Cancer Institute/Brigham
and Women's Hospital, Cancer Imaging
Board Certification: Radiology
Areas of Expertise: Gynecologic imaging, Genitourinary
imaging, Sarcoma
Medical School: B.J. Medical College, India
call 877-332-4294
www.dana-farber.org
30
Radiation Oncology
The Department of Radiation Oncology plays a central role in treating adults and children with cancer. Our clinicians have specialized knowledge
in treating each type of cancer for which radiation therapy is indicated, and we work collaboratively with specialists across our disease-specific
treatment centers to develop an individualized radiation therapy plan for each patient, and provide supportive resources before and after treatment.
Our team also has an active research program that includes both basic (laboratory) and clinical research. Our research often involves collaboration
with other departments as we strive to better identify and treat cancer, and to develop ways to deliver higher doses of radiation to the tumor area
while reducing the effects to the surrounding healthy tissue.
New Patient Appointment Phone: (877) 332-4294
Leadership - Radiation Oncology
Jay R. Harris, MD, Chair
Treatment Team
Radiation Oncology
Ayal Aizer, MD, MHS
Brian M. Alexander, MD, MPH
Nils Arvold, MD
Tracy Anne Balboni, MD, MPH
Elizabeth H. Baldini, MD, MPH
Clair J. Beard, MD
Bruce B. Borgelt, MD, PhD, MPH
Aileen B. Chen, MD, MPP
Michael N. Corradetti, MD, PhD
Anthony V. D'Amico, MD, PhD
Phillip M. Devlin, MD, FACR
Raymond L. Dugal, MD
Jay R. Harris, MD
Alec Kimmelman, MD, PhD
Benjamin L. King, MD
David E. Kozono, MD, PhD
Monica S. Krishnan, MD
call 877-332-4294
Jason H. Lee, MD
Larissa Lee, MD
Tatiana I. Lingos, MD
Stephanie G. MacAusland, MD
Raymond H. Mak, MD
Harvey J. Mamon, MD, PhD
Karen J. Marcus, MD
Danielle N. Margalit, MD, MPH
Peter M. Mauch, MD
Paul L. Nguyen, MD
Peter F. Orio, III, DO
Michael E. Pacold, MD, PhD
Itai M. Pashtan, MD
Susan M. Pierce, MD
William D. Powlis, MD
Rinaa S. Punglia, MD, MPH
Ron Y. Shiloh, MD
Alexander Spektor, MD, PhD
Jacqueline E. Tan, MD
Roy B. Tishler, MD, PhD
Akila N. Viswanathan, MD, MPH
Julia S. Wong, MD
www.dana-farber.org
31
Radiation Oncology - Radiation Oncology
Title: Physician
Residency: Harvard Radiation Program, Radiation
Oncology
Fellowship: Harvard School of Public Health
Area of Expertise: Head and neck cancers
Phone: 617-632-3591
Fax: 617-632-4247
E-mail: jschoenfeld@lroc.harvard.edu
Ron Y. Shiloh, MD
Title: Network Physician
Academic Title: Clinical Instructor in Radiation
Oncology, Harvard Medical School
Phone: 508-488-3800 (Milford)
781-624-5700 (South Shore)
Fax: 508-488-2000 (Milford)
781-331-1057 (South Shore)
E-mail: rshiloh@lroc.harvard.edu
Medical School: Emory University School of Medicine
Residencies: Harvard Combined Medicine-Pediatrics
Program, Internal Medicine;
Northwestern University, Radiation
Oncology
Fellowship: Harvard Palliative Medicine Program,
Dana-Farber Cancer
Institute/Massachusetts General
Hospital, Palliative Medicine
Pediatrics
Radiation Oncology
Areas of Expertise: Breast cancer, Lung cancer,
Gastrointestinal cancer, Palliative care,
Image-guided radiation therapy,
Intensity-modulated radiation therapy
Alexander Spektor, MD, PhD
Area of Expertise: Palliative radiation oncology
Phone: 617-632-3591
Fax: 617-632-4247
E-mail: aspektor@partners.org
Medical School: New York University School of
Medicine
Residency: Harvard Radiation Oncology Program
call 877-332-4294
www.dana-farber.org
32
DF/BWCC at Milford
Dana-Farber/Brigham and Women’s Cancer Center at Milford Regional Medical Center offers expert cancer care close to home for patients in the
Tri-County area. At the Milford location, Dana-Farber provides hematology and medical oncology treatment, Brigham and Women’s Hospital
provides radiation therapy, and Milford Regional Medical Center offers diagnostic imaging and laboratory services. Surgical services are offered by
Brigham and Women’s Hospital surgeons for thoracic and gynecologic surgery and through Milford Regional Medical Center’s Breast Health Center
for breast surgery.
Through second-opinion clinics, community physicians and their patients can leverage the expertise of DF/BWCC subspecialists to discuss
diagnoses and treatment plans. Surgical consults with gastrointestinal surgeons from Brigham and Women’s Hospital are also available. The Center
also offers specialized support programs such as high risk screening, genetic counseling, and survivorship services.
New Patient Appointment Contact Information:
Medical and Surgical Oncology Phone: 508-488-3700; Fax: 508-488-2016
Radiation Oncology Phone: 508-488-3800; Fax: 508-488-2000
Leadership – DF/BWCC at Milford Regional Medical Center
Michael Constantine, MD, Medical Director, Medical Oncology
Peter F. Orio, III, DO, Medical Director, Radiation Oncology
Treatment Team
Hematology/Oncology
Michael Constantine, MD
Mona S. Kaddis, MD
Humberto A. Rossi, MD
Natalie Sinclair, MD
Naeem Tahir, MD
Radiation Oncology
Ron Y. Shiloh, MD
Surgical Oncology
Ciaran J. McNamee, MD
Medical & surgical oncology: (508) 488-3700,
Radiation oncology: (508) 488-3800
www.dana-farber.org/milford
33
DF/BWCC at Milford - Hematology/Oncology
Natalie Sinclair, MD
Discipline: Hematology/Oncology
Phone: 508-488-3700
E-mail: natalie_sinclair@dfci.harvard.edu
Medical School: University of Vermont
Fellowship: Brown University,
Hematology/Oncology
Board Certification: Internal Medicine
Areas of Expertise: Thoracic oncology, Breast oncology,
Benign and malignant hematology
Residency: University of Vermont, Internal
Medicine
DF/BWCC at Milford - Radiation Oncology
Ron Y. Shiloh, MD
781-624-5700 (South Shore)
Fax: 508-488-2000 (Milford)
781-331-1057 (South Shore)
Oncology
Dana-Farber Cancer
Pediatrics
Radiation Oncology
Medical & surgical oncology: (508) 488-3700,
Radiation oncology: (508) 488-3800
www.dana-farber.org/milford
34
DF/BWCC with South Shore Hospital
At Dana-Farber/Brigham and Women’s Cancer Center in clinical affiliation with South Shore Hospital, residents of the South Shore have access to
the highest level of cancer care south of Boston. The Center offers state-of-the-art imaging, hematology, medical and radiation oncology,
multidisciplinary surgical oncology, and complete breast health services. Community physicians and their patients can also meet with DF/BWCC
subspecialists in hematology and breast, gastrointestinal and neuro-oncology through monthly second opinion clinics. Specialized programs in
genetics counseling and survivorship are also available to patients.
New Patient Referral Contact Information
Medical Oncology Phone: 781-624-4681; Fax: 781-624-2620
Radiation Oncology Phone: 781-624-4700; Fax: 617-394-2674
Multispecialty Surgical Services Phone: 781-624-4760; Fax: 781-624-4766
Breast Care Center Phone: 781-624-4545; Fax: 781-624-4614
Leadership – DF/BWCC in clinical affiliation with South Shore Hospital
Meredith Faggen, MD, Medical Director, Medical Oncology
Peter F. Orio, III, DO, Medical Director, Radiation Oncology
Thomas E. Clancy, MD, FACS, Medical Director, Multispecialty Surgical Oncology
Suniti N. Nimbkar, MD, FACS, Medical Director, Breast Care Center
Treatment Team
Dermatology
Allison Goddard, MD
Hematology/Oncology
Meredith Faggen, MD
Rolf Freter, MD, PhD
Lisa Manera, MD
Reve P. Shields, MD
Plastic Surgery
Douglas L. Helm, MD
Radiation Oncology
Bruce B. Borgelt, MD, PhD, MPH
Benjamin L. King, MD
Itai M. Pashtan, MD
Ron Y. Shiloh, MD
Surgical Oncology
Katherina Zabicki Calvillo, MD, FACS
Thomas E. Clancy, MD, FACS
Christopher T. Ducko, MD
John J. Froio, MD
Suniti N. Nimbkar, MD, FACS
call 781-624-5000
www.dana-farber.org/southshore
35
DF/BWCC with South Shore Hospital Hematology/Oncology
Reve P. Shields, MD
Phone: 781-624-4800
Fax: 781-624-4840
E-mail: reve_shields@dfci.harvard.edu
Fellowship: Brown University, Alpert School of
Medicine, Medical
Oncology/Hematology
Board Certifications: Hematology
Internal Medicine
Medical Oncology
Medical School: State University of New York, Upstate
Medical University
Residency: Brown University, Alpert School of
Medicine
DF/BWCC with South Shore Hospital - Radiation Oncology
Ron Y. Shiloh, MD
781-624-5700 (South Shore)
Fax: 508-488-2000 (Milford)
781-331-1057 (South Shore)
Oncology
Dana-Farber Cancer
Pediatrics
Radiation Oncology
call 781-624-5000
www.dana-farber.org/southshore
36
Dana-Farber/NHOH
Dana-Farber/New Hampshire Oncology-Hematology (Dana-Farber/NHOH) provides expert hematology and medical oncology treatment in
Londonderry, NH. Through Dana-Farber/NHOH, patients receive the benefits of Dana-Farber's advances in care and research, while staying close
to home.
In addition, through second-opinion consults, physicians and their patients can discuss diagnoses and treatment plans with Dana-Farber
subspecialists. The Center also provides an array of specialized and support services to patients and families, including select Dana-Farber clinical
trials, high-risk screening and genetic counseling, nutrition services and survivorship,.
Fax: 603-552-9111
Leadership – Dana-Farber/NHOH
Jeanna Walsh, MD, Medical Director
Treatment Team
Hematology/Oncology
Frederick M. Briccetti, MD
Meredith J. Selleck, MD
Jeanna H. Walsh, MD
call (603) 552-9100.
www.dana-farber.org/londonderry
37
Dana-Farber/NHOH - Hematology/Oncology
Meredith J. Selleck, MD
Phone: 603-552-9100
Fellowship: Columbia Presbyterian Medical Center
Oncology
Fax: 603-552-9105
E-mail: meredith_selleck@dfci.harvard.edu
Medical School: New York Medical College
Residency: Columbia Presbyterian Medical Center
call (603) 552-9100.
www.dana-farber.org/londonderry
38
Dana-Farber Community Cancer Care physician practices enable patients to receive the latest medical oncology and hematology care in a
community setting of a physician office. With several locations throughout eastern Massachusetts, patients have many options to access DanaFarber care in their communities and benefit from the advances in cancer care and research made by Dana-Farber in Boston.
Refer a patient to one of our locations by calling:
Dorchester: 617-296-1265
Haverhill: 978-521-8590
Lawrence: 978-946-8230
Milton: 617-698-0779
Newburyport: 978-465-0298
Quincy: 617-479-3550
Stoneham: 781-279-9047
Weymouth: 781-337-9091
Leadership – Dana-Farber Community Cancer Care Physician Practices
Michael J. Anderson, MD, Executive Medical Director
Treatment Team
Hematology/Oncology
Mark E. Anderson, MD
Michael J. Anderson, MD
Alexandra S. Bailey, MD
Darren M. Evanchuk, MD
James R. Everett, MD
Catherine Iasiello, MD
Nasima Khatoon, MD
Marina Z. Khitrik-Palchuk, MD
Yamil H. Kouri, MD
Sarah K. May, MD
Paul C. Musto, MD
Thomas P. O'Connor, Jr., MD
Anne E. Roberge, MD
Pedro M. Sanz-Altamira, MD, PhD
To refer an patient,
call 617-479-3550.
www.dana-farber.org
39
Dana-Farber Community Cancer Care Hematology/Oncology
Pedro M. Sanz-Altamira, MD, PhD
Title: Senior Network Physician
Phone: 978-946-8230
Fax: 978-946-8226
Medical School: Seville University Medical School
Graduate School: Hannover Medical School, PhD
Residency: Newton-Wellesley Hospital, Internal
Medicine
To refer an patient,
call 617-479-3550.
Fellowship: Beth Israel Deaconess Medical Center,
Hematology-Oncology
Internal Medicine
Medical Oncology
Note: Dr. Sanz-Altamira sees patients at the
physician practice in Lawrence.
www.dana-farber.org
40
Pediatric Blood Disorders
Our Pediatric Blood Disorders team is internationally known for its wide range of clinical, research, teaching, and laboratory services. We have
special expertise treating patients and families with all forms of non-malignant blood disorders, including anemia, bone marrow failure syndromes,
bleeding problems, blood clots (thrombosis), platelet disorders including idiopathic thrombocytopenic purpura (ITP), sickle cell disease, and white
blood cell disorders.
Patients receive care from a team of pediatric hematologists, nurses, nurse practitioners, social workers, and physician assistants. Immunologists,
pathologists, clinical dietitians, and other specialists also contribute to this team. As a group, we develop individualized care plans that meet the
medical, physical, emotional, and informational needs of our patients and families. We believe families and referring physicians are especially
important in the long-term health management plans of children with blood disorders, and we involve them in all treatment decisions.
We oversee the pediatric arm of the Boston Hemophilia Center, a joint program with Brigham and Women’s Hospital. Our CAP/CLIA-certified
pathology laboratory delivers the highest quality results, and, with our oncology colleagues, we offer access to New England’s most successful and
advanced pediatric stem cell transplantation program.
Our basic science and clinical researchers are recognized for their contributions to improving the understanding and treatment of pediatric blood
disorders. We are one of six Centers for Disease Control-designated thalassemia treatment centers, and one of five national research centers for
Diamond-Blackfan anemia. We also participate in a National Institutes of Health-funded clinical trial network, overseeing studies for thalassemia,
transfusion medicine, and hemostasis. Our discoveries frequently lead to new clinical treatments that minimize the impact of these often life-long
conditions.
New Patient Appointment Phone: 617-355-8246, x 1
Fax: 617-730-0641
Leadership – Pediatric Blood Disorders Center
Matthew Heeney, MD, Clinical Director, Blood Disorders Center
Treatment Team
Pathology
Mark D. Fleming, MD, DPhil
Marian Harris, MD
Olga K. Weinberg, MD
Cameron C. Trenor, III, MD
Venee Tubman, MD
Katja G. Weinacht, MD, PhD
David A. Williams, MD
Hematology/Oncology
Natasha M. Archer, MD
Daniel Bauer, MD, PhD
Alan B. Cantor, MD, PhD
Stacy E. Croteau, MD, MMS
George Q. Daley, MD, PhD
Erica Esrick, MD
Rachael Grace, MD
Alejandro Gutierrez, MD
Matthew M. Heeney, MD
Jennifer C. Kesselheim, MD, M.Ed, MBE
Samuel E. Lux IV, MD
Alan D. Michelson, MD
David G. Nathan, MD
Ellis J. Neufeld, MD, PhD
Yana Pikman, MD
Raffaele Renella, MD, PhD
Colin A. Sieff, MB, BCh
call 888-733-4662
www.danafarberbostonchildrens.org
41
Pediatric Blood Disorders - Hematology/Oncology
Colin A. Sieff, MB, BCh
Academic Title: Associate Professor of Pediatrics,
Discipline: Pediatric Hematology/Oncology
Phone: 617-919-4241
Fax: 617-730-0641
Residency: Royal Marsden Hospital, St. George's
Hospital
Fellowship: Hospital for Sick Children, London
Board Certification: Hematology
Areas of Expertise: Bone marrow failure syndromes,
Diamond-Blackfan anemia
E-mail: colin.sieff@childrens.harvard.edu
Medical School: University of Witwatersrand
call 888-733-4662
42
Pediatric Brain Tumors
Our Pediatric Brain Tumor Center is the largest pediatric brain and spinal cord program in New England and is globally recognized for its expertise
in treating young cancer patients. The Neuro-Oncology Program brings together pediatric neurosurgeons, neuro-oncologists, neurologists, neuroradiologists, and radiation oncologists, among other specialists from Dana-Farber Cancer Institute and Boston Children’s Hospital, who are entirely
devoted to treating young patients with brain tumors. This team meets weekly to coordinate care while ensuring the highest possible functioning
and quality of life for every patient and their family.
As one of the leading research centers for the study of pediatric central nervous system tumors, our program offers access to advanced technologies
like the Intraoperative MRI, as well as unique treatment options through our extensive clinical trials program. We are members of the Pediatric
Oncology Experimental Therapeutic Investigator Consortium and were one of nine founding members of the Pediatric Brain Tumor Consortium.
These affiliations, as well as internally initiated medical studies, enable us to offer many treatments unavailable at other institutions.
For survivors of all ages, we provide specialized long-term care through the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic, which
helps survivors address any late-effects caused by brain tumors and their treatments, such as physical, psychological, social, and intellectual
challenges.
New Patient Appointment Phone: 617-632-2680 or 888-733-4662
Fax: 617-632-4897
Email: pedibraintumor@dfci.harvard.edu
Leadership – Pediatric Brain Tumor Center
Mark Kieran, MD, Director, Pediatric Medical Neuro-Oncology
Treatment Team
Neurology
Pathology
Emily Gertsch, MD
Scott L. Pomeroy, MD, PhD
Nicole Ullrich, MD, PhD
Umberto De Girolami, MD
Rebecca Dunn Folkerth, MD
Hart G. Lidov, MD
Keith L. Ligon, MD, PhD
Shakti Ramkissoon, MD, PhD
Neuro-Oncology
Pratiti (Mimi) Bandopadhayay, MBBS, PhD
Susan N. Chi, MD
Mark W. Kieran, MD, PhD
Michelle Lee, MD, PhD
Peter E. Manley, MD
Neurosurgery
Radiation Oncology
Karen J. Marcus, MD
Radiology
Tina Young Poussaint, MD, FACR
Alan R. Cohen, MD, FACS, FAAP
Liliana C. Goumnerova, MD
R. Michael Scott, MD
Edward R. Smith, MD
please call 888-733-4662
43
Pediatric Brain Tumors - Neurosurgery
Title: Christopher K. Fellows Family Chair in
Pediatric Neurosurgery, Boston
Children's Hospital
School
Discipline: Neurosurgery
Phone: 617-355-6011
Fax: 617-730-0906
E-mail: michael.scott@childrens.harvard.edu
Medical School: Temple University School of Medicine
Residency: Massachusetts General Hospital,
Neurosurgery
Fellowship: Research Fellowship, National Institute
of Neurological Diseases and Stroke,
Bethesda
Board Certifications: Neurological Surgery
Pediatric Neurosurgery
Areas of Expertise: Brain tumors, Arteriovenous
malformation (AVM), Chiari
malformation, Congenital
malformations, General neurosurgery,
Moyamoya, Myelodysplasia, Pediatric
stroke, Vascular anomalies and
malformations, Spinal cord tumors
Edward R. Smith, MD
Title: Director, Pediatric Cerebrovascular
Surgery, Boston Children's Hospital;
Co-Director, Center for Head, Neck,
and Skull Base, Boston Children's
Hospital; Co-Director, Stroke Program,
Boston Children's Hospital
Medical School
Residencies: Massachusetts General Hospital,
Pediatric Neurosurgery;
Massachusetts General Hospital, Surgery
Fellowship: Boston Children's Hospital, Pediatric
Neurosurgery
Board Certifications: Neurosurgery
Areas of Expertise: Pediatric brain tumors, Skull base
tumors, Spinal cord tumors
Phone: 617-355-8414
Fax: 617-730-0906
E-mail: edward.smith@childrens.harvard.edu
Medical School: Columbia University College of
Physicians & Surgeons
Pediatric Brain Tumors - Pathology
Neuropathology
Phone: 617-732-7510
E-mail: ssantagata@partners.org
Medical School: Mount Sinai School of Medicine
44
Pediatric Hematologic Malignancies
The hematologic malignancies team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is recognized for its expertise in treating
leukemia and lymphoma (including Hodgkin and non-Hodgkin lymphoma), diseases that comprise approximately one-third of all childhood cancer
cases. Our physicians head the Dana-Farber Cancer Institute ALL Consortium, an international organization focused on acute lymphoblastic
leukemia (ALL) treatment and research. Our treatment results for children with newly-diagnosed ALL are among the best published cure rates.
Fax: 617-582-7434
Email: pedi_onc@dfci.harvard.edu
Leadership – Pediatric Hematologic Malignancies Center
Lewis Silverman, MD, Clinical Director, Hematologic Malignancies Center
Treatment Team
Pathology
Mark D. Fleming, MD, DPhil
Marian Harris, MD
Olga K. Weinberg, MD
Hematology/Oncology
Prasanna Ananth, MD, MPH
Shelly C. Bernstein, MD, PhD
Amy L. Billett, MD
Kira Bona, MD, MPH
Brian D. Crompton, MD
Kimberly J. Davies, MD
Barbara A. Degar, MD
Erica Esrick, MD
Paola M. Friedrich, MD, MPH
Alejandro Gutierrez, MD
Andrew L. Hong, MD
Jennifer C. Kesselheim, MD, M.Ed, MBE
Birgit Knoechel, MD, PhD
Brenton Mar, MD, PhD
Stuart H. Orkin, MD
Barry H. Paw, MD, PhD
Andrew E. Place, MD, PhD
Raffaele Renella, MD, PhD
Stephen E. Sallan, MD
Lewis B. Silverman, MD
Kimberly Stegmaier, MD
Lynda M. Vrooman, MD
Loren D. Walensky, MD, PhD
Joanna S. Yi, MD
Radiation Oncology
Alan D. D'Andrea, MD
Karen J. Marcus, MD
Radiology
Stephan D. Voss, MD, PhD
45
Pediatric Hematologic Malignancies - Hematology/Oncology
Stephen E. Sallan, MD
Academic Title: Professor of Pediatrics, Harvard Medical
School
Phone: 617-632-3316
Fax: 617-632-5511
E-mail: stephen_sallan@dfci.harvard.edu
Residencies: Children's Hospital of Philadelphia;
Hospital for Sick Children, London,
England
Fellowship: Boston Children's Hospital/Dana-Farber
Cancer Institute, Pediatric
Hematology/Oncology
Board Certification: Pediatrics
Area of Expertise: Acute lymphoblastic leukemia (ALL)
Medical School: Wayne State University School of
Medicine
Lewis B. Silverman, MD
Title: Clinical Director, Pediatric Hematologic
Malignancies Center; Medical Director,
Inpatient Oncology; Institute Physician
Phone: 617-632-6191
Fax: 617-632-5710
Residency: Boston Combined Residency Program,
Boston Children's Hospital/Boston
Medical Center, Pediatrics
Hematology/Oncology
Board Certification: Pediatric Hematology/Oncology
Area of Expertise: Acute lymphoblastic leukemia (ALL)
E-mail: lewis_silverman@dfci.harvard.edu
Kimberly Stegmaier, MD
Title: Co-Director of the Pediatric
Hematologic Malignancy Program;
Physician
Phone: 617-632-4985
Fax: 617-632-4850
E-mail: kimberly_stegmaier@dfci.harvard.edu
Hematology/Oncology
Board Certification: Pediatric Hematology/Oncology
Areas of Expertise: Chemical screening, Neuroblastoma,
Ewing Sarcoma, Hematologic
malignancies, Cancer genomics
46
Pediatric Psychosocial Oncology
Psychosocial care is an integral part of cancer treatment. When a child is diagnosed with cancer, the entire family is affected. Our multidisciplinary
staff provides emotional support and a full range of psychosocial and behavioral consultation services not only to patients, but also to parents,
siblings, the extended family and to schools and other community-based providers. Our comprehensive clinical care team helps patients and their
families develop personalized treatment plans that optimize coping and help define treatment goals and concerns.
Leadership – Pediatric Psychosocial Oncology
Anna (Nina) C. Muriel, MD, Chief
Treatment Team
Psychiatry
Anna (Nina) C. Muriel, MD
Chase Samsel, MD, FAAP
Psychology
Sarah Brand, PhD
Brian L. Delaney, PsyD
Cori Liptak, PhD
Lisa M. Northman, PhD
Christopher John Recklitis, PhD, MPH
Sarah Tarquini, PhD
47
Pediatric Psychosocial Oncology - Psychiatry
Chase Samsel, MD, FAAP
Title: Physician
Academic Title: Instructor in Psychiatry, Harvard
Medical School
Discipline: Psychiatry
Phone: 617-632-6560
Fax: 617-632-5677
E-mail: chase_samsel@dfci.harvard.edu
Medical School: Medical College of Georgia
Residency: Brown University, Combined Program
in Pediatrics/Adult Psychiatry/Child
Psychiatry
Fellowship: Brown University, Combined Program
in Pediatrics/Adult Psychiatry/Child
Psychiatry
Board Certifications: Pediatrics
Psychiatry
Areas of Expertise: Pediatric palliative psychiatry, Medicalpsychiatric illness, Complex chronic
care, Psychodynamic psychotherapy,
Psychosomatic medicine, Pediatrics and
psychiatry interface, Self-hypnosis
48
Pediatric Solid Tumors
Our Solid Tumor Center combines the expertise of clinicians at Dana-Farber Cancer Institute and Boston Children's Hospital to provide
comprehensive care for children and teens with benign or malignant bone and soft tissue tumors. Patients receive care from a multidisciplinary team
that includes pediatric oncologists, radiation oncologists, surgeons, pathologists, radiologists, nurses, and psychosocial and physical therapy
specialists.
In addition, we provide long-term treatment and childhood cancer survivor support through Dana-Farber’s David B. Perini, Jr. Quality of Life
Clinic.
Fax: 617-582-7434
Leadership – Pediatric Solid Tumor Center
Carlos Rodriguez-Galindo, MD, Clinical Director, Solid Tumor Center
Treatment Team
Pathology
Radiology
Theonia K. Boyd, MD
Monica Hollowell, MD
Harry P.W. Kozakewich, MD
Kyle C. Kurek, MD
Antonio R. Perez-Atayde, MD
Birgitta A.R. Schmidt, MD
Lisa A. Teot, MD
Sara O. Vargas, MD
Susan Connolly, MD
Kirsten Ecklund, MD
Hematology/Oncology
Surgical Oncology
Megan E. Anderson, MD
Mark C. Gebhardt, MD
Richard S. Lee, MD
Robert C. Shamberger, MD
Christopher B. Weldon, MD, PhD
Richard N. Yu, MD, PhD
Prasanna Ananth, MD, MPH
Brian D. Crompton, MD
Lisa R. Diller, MD
Erica Esrick, MD
A. Lindsay Frazier, MD
Paola M. Friedrich, MD, MPH
Rani E. George, MD, PhD
Holcombe E. Grier, MD
Andrew L. Hong, MD
Katherine A. Janeway, MD
Junne Kamihara, MD, PhD
Jennifer W. Mack, MD, MPH
Elizabeth A. Mullen, MD, FAAP
Allison F. O'Neill, MD
Charles W. Roberts, MD, PhD
Carlos Rodriguez-Galindo, MD
Suzanne Shusterman, MD
49
Pediatric Solid Tumors - Hematology/Oncology
Suzanne Shusterman, MD
Academic Title: Assistant Professor of Pediatrics,
Phone: 617-632-4901
Fax: 617-632-5710
E-mail: suzanne_shusterman@dfci.harvard.edu
Fellowship: Children's Hospital of Philadelphia,
Pediatric Hematology/Oncology
Board Certifications: Pediatrics
Pediatric Hematology/Oncology
Areas of Expertise: Neuroblastoma, Solid tumors
Medical School: University of Massachusetts
Pediatric Solid Tumors - Pathology
Birgitta A.R. Schmidt, MD
Academic Title: Instructor in Pathology, Harvard
Medical School
Phone: 617-355-7431
Fax: 617-730-0207
Residency: Brigham and Women's Hospital
Fellowship: Brigham and Women's Hospital
Board Certifications: Dermatopathology
Pathology
Area of Expertise: Pediatric dermatopathology
E-mail: birgitta.schmidt@childrens.harvard.edu
Medical Schools: Mora Hospital, Sweden;
Uppsala Akademiska Hospital, Sweden
Pediatric Solid Tumors - Surgical Oncology
Title: Chief, Department of Surgery, Boston
Children's Hospital
Academic Title: Robert E. Gross Professor of Surgery,
Harvard Medical School; Chair, Section
of Surgery, American Academy of
Pediatrics
Phone: 617-355-8326
Fax: 617-730-0299
Fellowships: Boston Children's Hospital, Pediatric
Surgery;
Surgery Branch-National Cancer
Institute, Pediatric Oncology
Board Certifications: Pediatric Surgery
Surgery
Surgical Critical Care
Areas of Expertise: Inflammatory bowel disease, Pediatric
general surgery, Surgical critical care,
Surgical oncology, Thoracic surgery
E-mail: robert.shamberger@childrens.harvard.edu
Residency: Massachusetts General Hospital, Surgery
50
Pediatric Surgical Oncology
Surgery often plays a critical role in overall cancer treatment. Our pediatric surgical oncology team consists of experts with extensive experience in
various types of cancers, including neuroblastoma, brain and bone tumors, as well as other rare and hard-to-treat cancers.
Because of the number of cases we see, our pediatric surgeons have a true appreciation of the issues that may be encountered. They are able to bring
perspective and expertise that can ultimately improve outcomes for our patients. Having this level of access to surgical oncology specialists allows us
to provide the best possible care for our patients. The partnership between our pediatric oncologists and surgeons in every specialty enables us to
quickly assess our patient’s needs and develop a cohesive, integrated and thoughtful approach to his or her care.
Treatment Team
Neurosurgery
Alan R. Cohen, MD, FACS, FAAP
Liliana C. Goumnerova, MD
Edward R. Smith, MD
Surgical Oncology
Megan E. Anderson, MD
Mark C. Gebhardt, MD
Christopher B. Weldon, MD, PhD
please call (888) 733-4662
www.dana-farber.org
51
Pediatric Surgical Oncology - Neurosurgery
Title: Christopher K. Fellows Family Chair in
Pediatric Neurosurgery, Boston
Children's Hospital
School
Phone: 617-355-6011
Fax: 617-730-0906
E-mail: michael.scott@childrens.harvard.edu
Medical School: Temple University School of Medicine
Residency: Massachusetts General Hospital,
Neurosurgery
Fellowship: Research Fellowship, National Institute
of Neurological Diseases and Stroke,
Bethesda
Board Certifications: Neurological Surgery
Areas of Expertise: Brain tumors, Arteriovenous
malformation (AVM), Chiari
malformation, Congenital
malformations, General neurosurgery,
Moyamoya, Myelodysplasia, Pediatric
stroke, Vascular anomalies and
malformations, Spinal cord tumors
Edward R. Smith, MD
Title: Director, Pediatric Cerebrovascular
Surgery, Boston Children's Hospital;
Co-Director, Center for Head, Neck,
and Skull Base, Boston Children's
Hospital; Co-Director, Stroke Program,
Boston Children's Hospital
Medical School
Residencies: Massachusetts General Hospital,
Pediatric Neurosurgery;
Massachusetts General Hospital, Surgery
Fellowship: Boston Children's Hospital, Pediatric
Neurosurgery
Board Certifications: Neurosurgery
Areas of Expertise: Pediatric brain tumors, Skull base
tumors, Spinal cord tumors
Phone: 617-355-8414
Fax: 617-730-0906
E-mail: edward.smith@childrens.harvard.edu
Medical School: Columbia University College of
Physicians & Surgeons
Pediatric Surgical Oncology - Surgical Oncology
Title: Chief, Department of Surgery, Boston
Children's Hospital
Academic Title: Robert E. Gross Professor of Surgery,
Harvard Medical School; Chair, Section
of Surgery, American Academy of
Pediatrics
Phone: 617-355-8326
Fax: 617-730-0299
Fellowships: Boston Children's Hospital, Pediatric
Surgery;
Surgery Branch-National Cancer
Institute, Pediatric Oncology
Board Certifications: Pediatric Surgery
Surgery
Surgical Critical Care
Areas of Expertise: Inflammatory bowel disease, Pediatric
general surgery, Surgical critical care,
Surgical oncology, Thoracic surgery
E-mail: robert.shamberger@childrens.harvard.edu
Residency: Massachusetts General Hospital, Surgery
please call (888) 733-4662
www.dana-farber.org
52

Medical Oncology - Dana-Farber Cancer Institute

Transcription

Similar documents

Foreword - touchONCOLOGY

senior radiotherapy medical physicist doha, qatar

Treatment Planning: Flexible Options

HERE - MSR

PHYSICIAN Dedicated to Discovery … Committed to Care dana-farber

CvSSS

PHYSICIAN Dedicated to Discovery … Committed to Care dana-farber

Bionest Oncology Capabilities 2016

Thoracic Oncology - Find a Doctor - Dana

10 MEETING OF LIFE SCIENCE DOCTORAL STUDENTS ... , 2014